1st Quarter - Report

THE ALS ASSOCIATION for THE ALS ASSOCIATION

Firm
Client
Income
—
Expenses
$25,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Promising Pathways Act (draft legislation. no bill number) - would create a provisional approval path for drugs and biological interventions that meet unmet needs of rare diseases like ALS.

LobbyistCovered position, as disclosed
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Justice for ALS Veterans Act (draft legislation. no bill number) -- All Provisions, including those extending Dependency and Indemnity Compensation payments to surviving spouses of veterans who die from ALS, regardless of how long a veteran had ALS prior to death.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Conversations surrounding Appropriations for Fiscal Year 2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations (no bill number) --Requested that the House and Senate Appropriations LHHS Subcommittee provide at least $150 million for ALS research at NIH in fiscal year 2024 to attract the next generation of scientists, accelerate the discovery and development of new treatments and increase the number of ALS clinical trials. Requested at least $75 000,000 to implement the expanded access program established by the ACT for ALS Act (P.L. 117-79). Requested at least $15 million to continue the National ALS Registry and Biorepository in fiscal year 2024 to help identify risk factors for ALS to reduce the number of new cases, connect patients with clinical trials, conduct surveillance of incidence and prevalence and biospecimens, and support research of ALS prevention in the military. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (no bill number) --Requested the House and Senate Appropriations Agriculture Subcommittee provide at least $25 million specifically for ALS research to the FDA Orphan Products Grants Program in fiscal year 2024 to fund P.L. 117-79 the FDA Rare Neurodegenerative Disease Grant Program which is authorized to provide ALS research grants. Department of Defense Appropriations Act (no bill number) -- Requested the House and Senate Appropriations Defense Subcommittee provide at least $80 million for the ALS Research Program in fiscal year 2024 to allow the program to build on a solid foundation of promising preclinical research to increase the number of ALS clinical trials by funding its own early phase trials.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

ALS Better Care Act (Draft Legislation. no bill number) - Provides supplemental payment to designated ALS clinics that provide multidisciplinary services to people living with ALS. Discussion around Telehealth permanence (no bill number) - provisions related to permanent telehealth services in Medicare and interstate telehealth services.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Discussion around Telehealth permanence (no bill number) - provisions related to permanent telehealth services in Medicare and interstate telehealth services. Protecting Health Care for All Patients Act of 2023 (H.R. 485) - provisions to ban the usage of quality adjusted life years in public insurance programs. Elizabeth Dole Home Care Act of 2023 (H.R. 542/S.141) - would raise the cap on the Veterans Administrations payments for home care from 65% to 100% and would expand VA home care programs. HELP Copays Act (H.R.830) -- Provisions related to health insurance plans requirement to apply payments made by or on behalf of plan enrollees toward a plan's cost-sharing requirements, i.e. a ban on copay-accumulator adjust programs.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 141 (118th), H.R. 542 (118th), H.R. 830 (118th), H.R. 485 (118th)

Aviation/Airlines/Airports AVI

Air Carrier Access Amendments Act (H.R.1267/S.545) -- provisions related to prohibiting discrimination against disabled individuals by an air carrier. Emergency Vacating of Aircraft Cabin (EVAC) Act (draft legislation. No bill number) - Require FAA to establish evacuation standards for aircrafts taking inconsideration the needs of people with disabilities who need to exit an aircraft in an emergency.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1267 (118th), S. 545 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.